Revenue

Gaxos.ai's strategic pivot away from gaming has fueled a massive revenue surge. But beyond the headline numbers, can it achieve profitability and prove its AI identity?

With two veteran hires, NFI signals a strategic assault on the complex eCommerce logistics market. It's a calculated play for dominance in fulfillment.

The premium pet food brand is moving beyond ingredients, betting its largest-ever investment on an emotional campaign built on a foundation of radical transparency.

With battle-tested AI trained on millions of images from Ukraine, Safe Pro Group is proving its drone tech can clear minefields 800% faster. But can it scale?

As GrowGeneration preps its Q2 earnings, investors are watching. Will its pivot to proprietary brands and B2B sales prove its turnaround is real?

The travel club's Q2 results reveal deep losses and cash burn from its new membership model, testing investor faith amidst geopolitical headwinds.

As Riot Platforms preps its Q2 earnings call, the real story isn't just Bitcoin. It's a strategic pivot to building the massive infrastructure for our digital future.

NextPlat declares a strategic turnaround, but the real story is its complex model: blending high-margin healthcare with niche satellite tech. Can it deliver?

The addition of a top international tax expert is more than a personnel move; it's the first major signal of how TPG's capital is arming Smith + Howard for a national expansion.

AMD's massive deal with Core Scientific reveals a new front in the AI war: infrastructure. Securing gigawatts of power signals a strategic shift beyond silicon.

As DoubleDown Interactive preps its Q2 report, all eyes are on its European growth engine and a looming take-private offer from its parent company.

With two blockbuster cancer drugs driving revenue, Syndax's upcoming Q2 report is a critical test of its path to profitability and ambitious pipeline.

After a costly transformation including the 'Amazon glide down,' UPS posts strong adjusted Q2 profits and raises guidance, proving its pivot to higher-margin business is working.

A 49% stock plunge and a major acquisition write-down have thrust GeneDx into legal turmoil. We deconstruct the securities fraud claims and what they reveal.

A 57% stock plunge and a securities fraud lawsuit against Embecta Corp. reveal the high stakes of corporate guidance and the new era of accountability.

ADMA Biologics reported 20% growth, but a lawsuit alleges it was a sham built on channel stuffing and hidden deals. Here's what investors need to know.

A health tech innovator can't pay its auditors, triggering a full trading halt. We dissect ARCpoint's crisis and what it means for investors and the market.

With revenues falling and losses mounting, Vitalist Inc. is making a bold play. Can a new Reebok smartwatch and a pivot to medical AI save the company?

As Bakkt prepares its Q2 results, the fintech firm faces a critical test: can its pivot to AI and global payments justify its vision for a new financial system?

Navitas Semiconductor's shift to high-power markets is paying off. Q2 results show strong growth in AI infrastructure, proving its 'Navitas 2.0' pivot successful.